Does Rallies show 13F holders for ZTS?

Yes. Rallies tracks hedge fund and 13F ownership data for ZTS, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ZTS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ZTS. It does not provide personalized investment advice.

ZTS (ZOETIS INC.) Stock Analysis - Hedge Fund Holdings

ZOETIS INC. (ZTS) is a publicly traded Healthcare sector company. As of May 20, 2026, ZTS trades at $80.12 with a market cap of $32.58B and a P/E ratio of 13.29. ZTS moved +0.87% today. Year to date, ZTS is -37.33%; over the trailing twelve months it is -51.86%. Its 52-week range spans $72.38 to $197.51. Analyst consensus is buy with an average price target of $129.29. Rallies surfaces ZTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ZTS stock?

Hedge funds tracked by Rallies that own ZTS include Polen Capital, Pinebridge Investments, Soros Fund, Sculptor Capital, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for ZOETIS INC..

ZTS Key Metrics

Key financial metrics for ZTS
Metric	Value
Price	$80.12
Market Cap	$32.58B
P/E Ratio	13.29
EPS	$6.04
Dividend Yield	0.53%
52-Week High	$197.51
52-Week Low	$72.38
Volume	5.99M
Avg Volume	0
Revenue (TTM)	$9.51B
Net Income	$2.64B
Gross Margin	71.76%

Top Hedge Funds Holding ZTS

Polen Capital holds 4.22M shares of ZTS, changed -24.08% as of Mar 31, 2026.
Pinebridge Investments holds 155.93K shares of ZTS, changed +9.53% as of Sep 30, 2025.
Soros Fund holds 148.45K shares of ZTS, changed +0.00% as of Dec 31, 2025.
Sculptor Capital holds 55.67K shares of ZTS, changed +0.00% as of Dec 31, 2025.
Bridgewater Associates holds 50.74K shares of ZTS, changed -72.21% as of Mar 31, 2026.

Latest ZTS News

Zoetis Cuts 2026 EPS Guidance, Q1 Miss Sparks 4% Stock Slide — May 7, 2026
Zoetis hits new 52-week low near $113 as sentiment weakens ahead of earnings — Apr 29, 2026
Zoetis drops as stock turns ex-dividend, financing overhang keeps sentiment cautious — Apr 21, 2026
Zoetis Scores B in Value and VGM with 17.54 P/E, $6.97 Estimate — Mar 6, 2026
Zoetis Forecasts 9.3% Earnings Growth, Posts 6.2% Earnings Surprise — Mar 2, 2026

Recent ZTS Insider Trades

DAMELIO FRANK A bought 6.65K (~$501.34K) on May 13, 2026.
Bisaro Paul bought 2.00K (~$151.75K) on May 13, 2026.
MCCALLISTER MICHAEL B bought 3.00K (~$233.27K) on May 11, 2026.

ZTS Analyst Consensus

14 analysts cover ZTS: 0 strong buy, 8 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $129.29.

Common questions about ZTS

Who owns ZTS stock?: Hedge funds tracked by Rallies that own ZTS include Polen Capital, Pinebridge Investments, Soros Fund, Sculptor Capital, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for ZOETIS INC..
Does Rallies show 13F holders for ZTS?: Yes. Rallies tracks hedge fund and 13F ownership data for ZTS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ZTS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ZTS. It does not provide personalized investment advice.